AnaptysBio(GB:0HFQ)
$46.91-0.89 (-1.86%)
GB:0HFQ
AnaptysBio ownership
$46.91
At close:-0.89 (-1.86%)
AnaptysBio (0HFQ) Ownership - Who Owns AnaptysBio?
1 Followers
AnaptysBio (0HFQ) Ownership Overview
- 2.27% Insiders
- 12.74% Mutual Funds
- 59.67% Other Institutional Investors
- 13.49% ETFs
- 11.82% Public Companies and Individual Investors
The ownership structure of AnaptysBio (GB:0HFQ) stock is a mix of institutional, retail, and individual investors. Approximately 85.90% of the company’s stock is owned by Institutional Investors, 2.27% is owned by Insiders, and 11.82% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of AnaptysBio (GB:0HFQ) stock is a mix of institutional, retail, and individual investors. Approximately 85.90% of the company’s stock is owned by Institutional Investors, 2.27% is owned by Insiders, and 11.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 17, 2026 | Ecor1 Capital, Llc | $17,223,321 | |
| Mar 31, 2026 | John Schmid | $1,158,336 | |
| Mar 26, 2026 | Daniel Faga | $1,089,123 | |
| Jan 15, 2026 | Magda Marquet | $530,458 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Fisher Asset Management Llc | $2,742,222 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ecor1 Capital, Llc | 8,254,674 | Insider | 27.77% | 387,185,484 |
| BlackRock, Inc. | 1,891,512 | Institution | 6.36% | 88,721,370 |
| Ishares | 1,109,568 | Institution | 3.73% | 52,044,287 |
| Vanguard | 1,006,201 | Institution | 3.38% | 47,195,858 |
| Vanguard Index Funds | 885,178 | Institution | 2.98% | 41,519,274 |
| Spdr | 732,381 | Institution | 2.46% | 34,352,331 |
| Daniel Faga | 495,965 | Insider | 1.67% | 23,263,238 |
| Tiaa-cref Funds | 373,153 | Institution | 1.26% | 17,502,741 |
| Fidelity Salem Street Trust | 297,546 | Institution | 1.00% | 13,956,395 |
| Delaware Group Equity Funds Iv | 281,196 | Institution | 0.95% | 13,189,498 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 885,178 | Institution | 2.98% | 41,519,274 |
| Tiaa-cref Funds | 373,153 | Institution | 1.26% | 17,502,741 |
| Fidelity Salem Street Trust | 297,546 | Institution | 1.00% | 13,956,395 |
| Delaware Group Equity Funds Iv | 281,196 | Institution | 0.95% | 13,189,498 |
| Victory Portfolios Iii | 226,166 | Institution | 0.76% | 10,608,316 |
| Federated Hermes Equity Funds | 210,000 | Institution | 0.71% | 9,850,050 |
| Fidelity Concord Street Trust | 206,081 | Institution | 0.69% | 9,666,229 |
| Federated Hermes Mdt Series | 180,545 | Institution | 0.61% | 8,468,463 |
| Vanguard Horizon Funds | 162,550 | Institution | 0.55% | 7,624,408 |
| Vanguard Scottsdale Funds | 136,206 | Institution | 0.46% | 6,388,742 |
FAQ
Who Owns AnaptysBio (GB:0HFQ)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 85.90% of the company's stock is held by institutional investors, 2.27% is held by insiders, and 11.82% is held by public companies and individual investors.
What percentage of AnaptysBio (GB:0HFQ) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 85.90% of AnaptysBio (GB:0HFQ) stock is held by institutional investors: 12.74% by mutual funds, 13.49% by ETFs and 59.67% by other institutional investors.
What percentage of AnaptysBio (GB:0HFQ) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 11.82% of AnaptysBio (GB:0HFQ) stock is held by public companies and individual investors.
Who owns the most shares of AnaptysBio (GB:0HFQ)?
Ecor1 Capital, Llc owns the most shares of AnaptysBio (GB:0HFQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

